Back to AVTX

Avalo Therapeutics, Inc. 8-K

Accession 0001628280-19-004244

Filing information

CIK
0001534120
Report date
2019-04-10
Filing date
2019-04-12
Form
8-K
Primary document
cerc8-k20190412executivech.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.